Showing results (211-220 of 217) with videos related to
Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 217 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 18, 2026
Accelerating real-world prediction and research in Alzheimer's: The M3AD studyMoïse Desvarieux, Tatjana Rundek, Habibul Ahsan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology GroupAmy K Erbe, Wei Wang, Lakeesha Carmichael, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2023
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric CancerJoseph A Flores-Toro, Subhashini Jagu, Gregory T Armstrong, et al.Journal of the National Cancer Institute|March 9, 2024
Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor StudyDanielle Novetsky Friedman, Pamela J Goodman, Wendy M Leisenring, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory NeuroblastomaSteven G DuBois, Yael P Mosse, Elizabeth Fox, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2021
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT ConsortiumSteven G DuBois, M Meaghan Granger, Susan Groshen, et al.Nature Medicine|June 23, 2022
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancerAlanna J Church, Laura B Corson, Pei-Chi Kao, et al.Pageof 22